share_log
Reuters ·  Mar 27 08:22
Soleno Therapeutics Shares up 31.5% Premarket After US FDA Approved Co's Drug to Treat a Rare Genetic Disorder
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 231

Recommended

Write a comment